Robert T Abraham

Robert T Abraham

EVP and Head of Cancer Biology, Odyssey Therapeutics
Verified email at odysseytx.com
Cited by 58953
Professor John A Hartley

Professor John A Hartley

Professor of Cancer Studies
Verified email at ucl.ac.uk
Cited by 28889
Tarek Sahmoud

Tarek Sahmoud

Corporate VP, Celgene, Global Clinical Development
Cited by 27437
Tyler Curiel

Tyler Curiel

Dartmouth Health and Geisel School of Medicine at Dartmouth
Verified email at dartmouth.edu
Cited by 26811
Glenwood Goss

Glenwood Goss

The University of Ottawa
Verified email at toh.on.ca
Cited by 18543
Claire Verschraegen

Claire Verschraegen

The Ohio State University Comprehensive Cancer Center
Verified email at osumc.edu
Cited by 13019
David Bearss Ph.D.

David Bearss Ph.D.

University of Utah
Verified email at utah.edu
Cited by 13011
Lowell L Hart

Lowell L Hart

Assoc. Professor of Medicine, Wake Forest University and Florida Cancer Specialists
Verified email at wakehealth.edu
Cited by 11868
Richard Baird

Richard Baird

Cancer Research UK Cambridge Centre
Verified email at cam.ac.uk
Cited by 9269
Stephen Gately

Stephen Gately

CEO Translational Drug Development
Verified email at td2inc.com
Cited by 6014
1 - 10